Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum

Cecilia P. Sanchez*, Wilfred D. Stein, Michael Lanzer

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

56 Scopus citations

Abstract

Chloroquine (CQ), an antimalarial drug with a long history, now frequently fails in the field owing to the rapid spread of resistant Plasmodium falciparum strains. CQ resistance is linked to a K76T mutation in PfCRT, a membrane-located food vacuolar protein and member of the drug-metabolite transporter superfamily, but there is as yet no agreed mechanism of how mutated PfCRT brings about CQ resistance. Current models suggest that mutated PfCRT acts either as a channel or a transporter of CQ, enabling CQ to leave the digestive food vacuole of the parasite, in which the CQ accumulates. Here, we review the pros and cons of the carrier and transporter models in light of recent developments in the field.

Original languageEnglish
Pages (from-to)332-339
Number of pages8
JournalTrends in Parasitology
Volume23
Issue number7
DOIs
StatePublished - Jul 2007

Fingerprint

Dive into the research topics of 'Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum'. Together they form a unique fingerprint.

Cite this